Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack many tumour cell lines, and are thought to have a critical role in anti-tumour immunity; however, the interaction between NK cells and tumour targets is poorly understood. The stimulatory lectin-like NKG2D receptor is expressed by NK cells, activated CD8+ T cells and by activated macrophages in mice. Several distinct cell-surface ligands that are related to class I major histocompatibility complex molecules have been identified, some of which are expressed at high levels by tumour cells but not by normal cells in adults. However, no direct evidence links the expression of these 'induced self' ligands with tumour cell rejection. Here we demonstrate that ectopic expression of the murine NKG2D ligands Rae1beta or H60 in several tumour cell lines results in potent rejection of the tumour cells by syngeneic mice. Rejection is mediated by NK cells and/or CD8+ T cells. The ligand-expressing tumour cells induce potent priming of cytotoxic T cells and sensitization of NK cells in vivo. Mice that are exposed to live or irradiated tumour cells expressing Rae1 or H60 are specifically immune to subsequent challenge with tumour cells that lack NKG2D ligands, suggesting application of the ligands in the design of tumour vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NKG2D has been implicated in immune surveillance of tumors using transgenic models of spontaneous cancer as well as subcutaneous tumor transfer models (Cerwenka et al., 2001; Diefenbach et al., 2001; Guerra et al., 2008).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2001
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818 · cited 1×
“However, this was not the case with irradiated ligand-negative B16-BL6 tumour cell”
BackgroundInnate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“IFN-γ production was assayed by stimulating CTLs or NK cells with an equal number of target cells for 5–7 h and staining intracellular IFN-γ as describe”
MethodActivating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778 · cited 1×
“It is unknown whether engagement of NKG2D in NK cells results in direct stimulation or supplies a co-stimulatory signal that acts in conjunction with signals from other stimulatory receptor”
BackgroundDemonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232 · cited 1×
“Several distinct cell-surface ligands that are related to class I major histocompatibility complex molecules have been identifie”
BackgroundRole of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Cited by
Items 901–1,000 of 1,000
A discrete nonlinear model for HPV immune suppression and evasion
Solís, F. J., & Gonzalez, L. M. (2026) · Mathematical Biosciences · doi:10.1016/j.mbs.2026.109622 · Cited by 1
Camrelizumab exhibits dual specificity implications for antitumor immunity
Имянитов, Е. Н., Suladze, S. A., Peshkova, I. O., Tikhonov, A. A., & Buletov, D. A. (2026) · Head and neck tumors (HNT) · doi:10.17650/2222-1468-2025-15-4-41-51 · Cited by 1
Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer
George, J., Ma, X., Kadamberi, I. P., Nair, A., Mittal, S., Hashemi, E., Kumar, S., Singh, M., Geethadevi, A., Pradeep, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71468-y · Cited by 1
Innate immunity in tumors: From mechanisms to therapeutics
Hu, Y., Wang, X., Ma, H., & Zheng, X. B. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004116 · Cited by 1
Platelets as regulators of anti-tumor immunity: mechanisms and clinical implications
Schlesinger, M. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10362-x · Cited by 1
“Furthermore, NKG2D is recognized to play a fundamental role in the control of experimental tumor growth, metastases and host protection from de novo tumorigenesis [113, 114].”
Natural killer cells and allogeneic haematopoietic cell transplantation
Velardi, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00042-9 · Cited by 1
Immune Response and Immunotherapy in Chronic Lymphocytic Leukemia
Huergo-Zapico, L., Ana, P., Contesti, J., Fernndez-Guizn, A., Acebes‐Huerta, A., Lpez-Soto, A., & Gonzalez, S. R. (2012) · InTech eBooks · doi:10.5772/27086 · Cited by 1
“There are also defects on the expression of NKG2D and its ligands in CLL (Gasser et al., 2005; Groh et al., 1996, 1999; Diefenbach et al., 2001; Cerwenka et al., 2001; González et al., 2006).”
BackgroundStress-Induced Molecules in Regulation of NK Cell Activity
Kovalenko, E. I., Kanevskiy, L. M., Клинкова, А. В., Kuchukova, A., Streltsova, M. A., Telford, W. G., & Sapozhnikov, A. M. (2012) · InTech eBooks · doi:10.5772/48619 · Cited by 1
“A number of highly polymorphic “self” stressinduced proteins such as MICA, MICB and a group of UL16 binding proteins (ULBPs) are ligands of NKG2D [23-25].”
Immunological Sculpting: Natural Killer Cell Receptors and Ligands
Sallman, D. A., & Djeu, J. Y. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50069-9 · Cited by 2
Expression, purification and crystallization of the human UL16-binding protein ULBP1
Watson, A. A., Christou, C. M., & O’Callaghan, C. A. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.04.019 · Cited by 2
Korrer, M. J., & Routes, J. M. (2015) · Results in Immunology · doi:10.1016/j.rinim.2015.01.001 · Cited by 1
“In some tumor models, it appears that the ectopic expression of NKG2D ligands also induces antigenspecific, CD8þ anti-tumor immune responses [8].”
BackgroundDesigning Nonlinear Feedback Control for Controlling Tumor Growth
Pourhashemi, A., Haghighatnia, S., Moghaddam, R. K., & Mollaei, N. (2013) · Research Journal of Applied Sciences Engineering and Technology · doi:10.19026/rjaset.6.3515 · Cited by 1
“NK and CD8+T cells are capable of killing tumor cells (Diefenbach et al., 2001; Kawarada et al., 2001; Germain, 2004).”
BackgroundD, C. W. M., & M.D. (2011) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2011.8.279 · Cited by 1
Mason, A. L., & Rahbari, A. (2015) · Archives of Medicine · Cited by 1
Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice
Li, H., Fang, M., Dong, B., Guo, S., Cui, C., Liu, J., Yao, Y., Xiao, Y., Li, X., Ren, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10693 · Cited by 1
“In syngeneic mice, NKG2DL-transduced tumor cells could be rapidly rejected and failed to develop into detectable tumors [11], and mice deficient in NKG2D exhibited a higher incidence or greater severity of tumors [12].”
BackgroundLópez‐Larrea, C., López‐Soto, A., & Gonzalez, S. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00005-3 · Cited by 1
Dynamic aspects of tumour–immune system interaction under a periodic immunotherapy
Torres-Espino, G., & Zamora, M. (2021) · European Journal of Applied Mathematics · doi:10.1017/s0956792521000152 · Cited by 1
MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS
Akman, T., Köse, E., & Elliott, S. (2021) · Journal of Biological Systems · doi:10.1142/s0218339021500182 · Cited by 1
Reips, L., França, L. A. S., & Aleixo, R. (2021) · Proceeding Series of the Brazilian Society of Computational and Applied Mathematics · doi:10.5540/03.2021.008.01.0436 · Cited by 1
Pardoll, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50009-9 · Cited by 1
Natural killer cells in cancer
Höglund, P., & Ljunggren, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00004-1 · Cited by 2
Kshersagar, J. R., Bedge, P., Jagdale, R., Desai, S., Tardalkar, K. R., Jagadale, S., Jadhav, D. S., Toro, Y., & Joshi, M. G. (2022) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.30.131 · Cited by 1
Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy
Harlan, L. M., & Djeu, J. Y. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:045 · Cited by 1
Pathological Relevance of the Natural Immune System
Salvioli, S., Capri, M., Fumelli, C., Lescai, F., Franceschi, C., & Monti, D. (2005) · Neuroimmune biology · doi:10.1016/s1567-7443(05)80021-3 · Cited by 1
The Role of CD8 T Cells in the Control of Infectious Disease and Malignancies
Hsu, S. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0103 · Cited by 1
Coukos, G., & Conejo-Garcia, J. R. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:285 · Cited by 2
The Goldilocks Window of Personalized Chemotherapy: An Immune PerspectivePreprint
Park, D. S., Robertson‐Tessi, M., Maini, P., Bonsall, M. B., Gatenby, R. A., & Anderson, A. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/495184 · Cited by 1
Maggs, L. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Khan, S. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22198 · Cited by 2
Busche, A., Goldmann, T., Naumann, U., Steinle, A., & Brandau, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.17.ft-164 · Cited by 1
Hu, H., Chu, Y., & Urba, W. J. (2005) · Cancer treatment and research · doi:10.1007/0-387-27545-2_9 · Cited by 1
“Most importantly, mice vaccinated with tumor cells that express high levels of H60 or Rae-1 not only prevented tumor growth, but also induced CD8 T-cell dependent antitumor immunity [47, 48].”
BackgroundDelord, M. (2015) · theses.fr (ABES) · doi:10.70675/7de4a510zbee9z45c4za56aza35e488000e7 · Cited by 1
Chauvin, C. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Natural Killer Cells in the Treatment of Human Cancer
Malmberg, K., & Ljunggren, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-02309-5_22
Seidenberger, K. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-11122007-131612
Genetic and Expression Analyses of the 'Nkrp1-Clr' Gene Cluster
Zhang, Q. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6003
“The explanation could be that there are insufficient ligands expressed on the cell surface to trigger activating receptors (11-13).”
BackgroundGenetic Diversity in NK and NKT Cells
Allen, R. L., & Cooke, A. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50270-1
Hu, J. (2012) · Digital Commons-TMC (Texas Medical Center)
A mathematical model of tumor-immune interactions incorporated with danger model
Li, X., Xu, J., & Ren, Q. (2015) · Asian Control Conference (ASCC) · doi:10.1109/ascc.2015.7244639
“First of all, the specific biological assumptions are presented, many of which are based upon the findings of [15], which are frequently used [1], [3], [10]-[11].”
BackgroundIntercellular protein transfer and regulation of inhibitory NK receptor accessibility
Andersson, K. (2007) · Figshare
Nowbakht, P. (2005) · edoc (University of Basel) · doi:10.5451/unibas-003679595
Tumor Treatments Using Certain Drug Therapies: Mathematical Modelling
Tewari, M., & Sharma, Y. (2015) · Journal of Health, Medicine and Nursing
NK CELL RECOGNITION OF HERPESVIRUSES – MECHANISMS OF VIRAL IMMUNE ESCAPE
Rölle, A. (2008) · Figshare · doi:10.13140/2.1.1557.5365
Signaling in natural killer cells: SHIP, 2B4 and the Kinome
Wahle, J. A. (2007) · Digital Commons - University of South Florida (University of South Florida)
Humanized mice as a model to study human immunity
Heuts, F. W. H. (2012) · Figshare
Development of natural killer cells regulated by T-box transcription factors
Gordon, S. M. (2011) · ScholarlyCommons (University of Pennsylvania)
Evaluation of adoptive T cell therapy and oncolytic virotherapy for treatment of brain tumors
Thomas, D. (2010) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Immunotherapy of the Pancreatic Cancer
Yang, B. (2012) · InTech eBooks · doi:10.5772/28343
Mechanisms of Rejection of High Grade B cell Lymphoma in Mice
Sukumar, M. (2008) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10613
Influence of Ly49 inhibitory receptors and MHC class I on T cell and NK cell function
Öberg, L. (2005) · Figshare
Allogeneic Antitumor Vaccine Strategies
Laport, G. G., & June, C. H. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-333-0_18
Molecular specificities of NK cell-mediated recognition of human tumor cells
Carlsten, M. (2010) · Figshare · Cited by 1
MHC class I molecules in Natural Killer cell education and tolerance
Brodin, P. (2011) · Figshare
Update on vaccines for melanoma patients
Russo, V. E. A., Maccalli, C., Pilla, L., Mercuri, S. R., Orsenigo, E., Mukenge, S., Bregni, M., & Parmiani, G. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.2.195
Ogasawara, K. (2005) · Journal of Oral Biosciences · doi:10.2330/joralbiosci.47.1
A new approach to tumor immunotherapy
Heath, W. R. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02095-6
Bell, É. (2001) · Nature reviews. Immunology · doi:10.1038/35100537
How natural killer cells recognize cancer cells
Raulet, D. H. (2008)
Self-citationTRIGGERING AND MECHANISMS OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Bryceson, Y. T. (2008) · Figshare
The Innate Immune Response to Vaccinia Viral Infection
Martinez, J. (2010) · DukeSpace (Duke University) · Cited by 1
Target Cell Recognition by Natural Killer Cells: The NKG2D Receptor-Ligand System
Diefenbach, A., Jamieson, A. M., Hsia, J. K., Jensen, E. R., & Raulet, D. H. (2002)
Self-citationWhang, M. I., Guerra, N., & Raulet, D. H. (2009)
Self-citationCellsSurveillance of Unhealthy Cells by Natural Killer
Iannello, A., & Raulet, D. H. (2013)
Self-citationNKG2D Signaling and Cd8+ T Cells Survival in the Hypoxic Tumor Microenvironment
Neuburg, S. (2015) · Loyola eCommons (Loyola University of Chicago)
Rouzaire, P., Viel, S., Bienvenu, J., & Walzer, T. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_142
Role of the NKG2D Receptor in Health and Disease
Burgess, S. J., Narayanan, S., Borrego, F., & Coligan, J. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-512-5_28
Galani, I. E. (2008) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00008497
NK-Zell-vermittelte Immuntherapie von Hepatoblastomen
Warmann, S. W., Pfeiffer, M. M., Seitz, G., Ruck, P., Müller, C. A., Lang, P., Handgretinger, R., & Fuchs, J. (2008) · Langenbecks Archiv für Chirurgie. Supplement · doi:10.1007/978-3-540-78833-1_110
The Critical Role of PI3K-AKT-mTOR Pathway for IL-15 Induced NK Cell Effector Responses
Nandagopal, N. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3860
“Overexpressing these ligands leads to tumor rejection in vivo (Cerwenka et al., 2001; Diefenbach et al., 2001) and expression of these ligands in patients co-related with T cell infiltration in solid tumors (Vetter et al., 2002).”
BackgroundMechanisms of early immune activation in response to hepatitis B virus.
Vilarinho, S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/fkfa-fp52
NKG2D-vermittelte Lymphozytenaktivierung
Becker, J. C., Schrama, D., & L�hder, F. (2004) · Der Onkologe · doi:10.1007/s00761-004-0753-9
“Die Zerstörung größerer Tumoren führte auch zu einer Gedächtnisantwort gegenüber nachfolgend injizierten NKG2D-Ligandnegativen Tumorzellen [34].”
BackgroundInfluentialB cells as regulators of natural killer IFN-gamma production in mice
Haddad, E. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071562
Haploidentical Stem Cell Transplantation
Bimalangshu, R. D., & Spitzer, T. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-438-4_15
“NK cells also possess activating receptors, most notably NKG2D and NKp46, which can trigger NK cell alloreactivity when they are engaged by appropriate antigens on virally infected cells and tumor cells [18–21].”
BackgroundTranscription Factors Expression in NK and T Cells by Ap-1 Regulation of Human DAP10 Gene
Borrego, F., Coligan, J. E., Marusina, A. I., Burgess, S., & Pathmanathan, I. (2013)
Jänner, N. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15623
Regulation and Genetic Manipulation of Ligands for the Immunoreceptor NKG2D
Gowen, B. G. (2015) · eScholarship (California Digital Library)
High-Resolution Imaging of Natural Killer Cell Immunological Synapses
Oddos, S. (2010) · Spiral (Imperial College London) · doi:10.25560/6361 · Cited by 1
Role of Nitric Oxide-Signalling in Hypoxia-Induced Immune Escape in Cancer
Hamilton, T. K. (2011) · QSpace (Queen's University Library)
Fu, S. K. (2016) · UWA Profiles and Research Repository (University of Western Australia)
Killer cell immunoglobulin-like receptor(KIR)遺伝子領域の構造,ハプロタイプ,及び多型に関する解析
Geraghty, D. E. (2003) · Major Histocompatibility Complex · doi:10.12667/mhc.10.33
Andrews, D. M. (2004) · UWA Profiles and Research Repository (UWA)
Clough, S., Blair, G. E., Cook, G. P., Holmes, T. D., El-Sherbiny, Y. M., & Davison, A. (2013)
Immune responses against spontaneous tumors in a murine model for pancreatic adenocarcinoma
Garbe, A. I. (2004) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-200511080100-385
Gupta, N. (2013) · doi:10.21007/etd.cghs.2013.0120 · Cited by 1
“These observations were subsequently made in vivo as well [26, 27].”
BackgroundWoan, K. V. (2012) · University of Florida Digital Collections (University of Florida)
Mathematical Modeling in Improving Cancer Treatments
Li, X. (2018) · Unmanned Systems · doi:10.1142/s2301385018400083
Novel Fusion Protein IL-12/Fas TI for Cancer Immunogene Therapy
Yang, X. (2018) · TigerPrints (Clemson University)
Humoral and cell-mediated responses on cancer immune system - a study based on mathematical modeling
Tran, H. T. (2017) · NCSU Libraries Repository (North Carolina State University Libraries)
Recruitment of regulatory and conventional T cells to colon adenocarcinomas
Langenes, V. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Donnelly, R. P. (2016) · Arrow@dit (Dublin Institute of Technology)
Adenovirus vectors for manipulating human immune cells
Drake, S. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy
Mahasa, K. J. (2017) · SUNScholar (Stellenbosch University) · Cited by 1
Metadata
- Authors
- Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2001-09-13
- Volume
- 413
- Issue
- 6852
- Pages
- 165-171
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3900321
- OpenAlex
- W1595098530
- Cited by
- 1,083
- References
- 30
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 26 · 2023: 38 · 2022: 28 · 2021: 43 · 2020: 48 · 2019: 37 · 2018: 38 · 2017: 32 · 2016: 34 · 2015: 53 · 2014: 42 · 2013: 48 · 2012: 42
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- NKG2D, Rae1, NKG2D ligands, natural killer cells, tumour immunity, tumor rejection, CD8+ T cells, cancer vaccines, MHC class I
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Immunity, Killer Cells, Natural, Ligands, Membrane Proteins, Mice, Inbred C57BL, Neoplasms, Receptors, Immunologic, Recombinant Proteins, T-Lymphocytes, Cytotoxic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CD8-Positive T-Lymphocytes, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.